Member Info for TorquayFan

Yes GF - I don't follow the trades normally but it all looks like sells 13 - 13.065 ? odd ? ATB

Well it's all gone quiet over here - no posts since 12.55 yesterday ? Recent rises seem to have stalled but we'll see.

Inan has posted a reminder - 'On the eve of 1 month since first person dosed ... at full dosage - still no RNS on toxicity'.

Nice day all.

Ruck whilst 'no risk' is fairly said as 'utter codswallop', the remainder of those Inan posts is IMO worth a look - nice reminders. Inan in science mode is often worth reading. And I stand by the other comment about your posting there. Live with it. BFN

Ruck re. your 08.31. MMmmm. YOU are one of the main posters over there, who happily quarrel and quibble all day with Inan and make that BB unreadable. Many don't read it for that reason. So don't start on me now. I thought Inan had posted a series of nice reminders and sought to share one or two. That's it.

And BTW to describe those posts as 'utter codswallop' is a bit hard.

Thanks Burble and well said on 'no risk'.

In a series of nice reminders, 53061 :-

""Scancell is looking to near Double the efficacy of Keytruda

and "maybe" even higher with the "significant upgrade" Fc to FC (brand new patent)

keytruda with sales of $22 billion ............... can be improved

SCIB1 ....... no risk .. we know it works = high avidity killer t cell

synergy .........

between

KEYTRUDA is a type of immunotherapy that works by blocking the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA helps the immune system do what it was meant to do: detect and fight cancer cells""

The words 'no risk' appear again and no comment from me on that - let's hope the data is good.

Plenty to read over there today and thanks to Inan for all that.

Sorry that was 53058 . . . .

53059 - ""this market has a "spread"

from Keytruda £84,000 per patient

to $475,000, is Novartis' Kymriah

and everything else in between""

Inan starts the day in positive mode :-

""To become a "World Leader" ........ you need

"Novelty"

"A land grab patent"

"demand"

"low toxicity" (compared to chemo etc)

"simple to use" (an injection)

"able to work in multiple cancer types (costs)"

"proof of mechanism of action"

"funded to completion" . . .

that's all you need and Big Pharma will go crazy to get hold of the IP

the check point inhibitor market ...... proves the capacity of Big Pharma to go after the target with "unlimited" funding""

. . . . . MMmmmm - I look forward to that day !

Moonparty - good theory, you may well be right. I hope so. As Crumbs says, "only an RNS or a proper leak (media) will confirm. .". Otherwise could it be there's a change of sentiment as data gets closer? Maybe traders are buying back in now after taking it down? No idea but, long may the blue last !

RW ? What ? Simple you certainly are . . .
The filter is often mocked but in some cases, it's so good.
And mature not childish.

Whoops, that was 'clearer '.

Hi Dalester. Thanks for your questions. Re. the comments about the Modify patient, I merely sought to have it clear, and I did. The other matter was whether an RNS re. new developments can be manipulated for release timewise

You ask a question unrelated to either point - as to what qualifies as a new development. My personal uneducated take - I'd love to hear of even one person under say 'Modify', making a great improvement. And yes that would be OK for me as an announcement, (if it was true, not a joke). But I have no idea as to what the rules are, you need to ask someone else.

'Back' or white has nothing to do with it - AIM rules were relevant to some absurd suggestions.

If I have not answered you clearly, please make your point clear er next time. AIMHO. ATB

Oz - the 13419 trade at 13.066 IS a sale. Some of the others close to that, might be sales also. Bid is 12.75p.
Yes a rerate would be just lovely please.

Falsedawn thanks for your 21.15 and thanks Ruck for this - "I think the wording is pretty clear "MUST issue" , "WITHOUT DELAY", ANY new developments." Thanks very kindly indeed - whilst this is 'only' a BB it's good to be working on the correct information.

RW - "Scancell are probably as straight as they come" so they would not "tailor results to a date" ? It might be theoretically possible for an unscrupulous Company to do that but it is NOT 'entirely feasible" to "tailor results to a date" - that is clearly against AIM rules.

Chester - sorry to point this out but your 22.15 assertions are misleading.

WHEN there is news, I'm sure we'll hear promptly enough.

Let's hope for more blue today. GLA

Thanks Chester - you seem quite sure of this. May I ask your source for this assertion ?

RW I disagree completely. Never mind.

Sorry LL. Yes it could be your fault and many thanks.

Hi Balerno. I still disagree. Maybe someone else can clarify . . . .

Balerno - can't agree with that. No clinical or business news will be withheld for any reason when it does actually occur. IMHO and ATB

Thanks Bobbust for explaining that. No problem . . .

With so many waiting for, quote, 'dreams to fly', normal levity can be a problem.

I wish it were true though. Maybe it is . . . . . . ATB